As a biological CRO company, Biologics International Corp (hereinafter referred to as BIC) has long devoted itself to the R&D of technologies related to recombinant protein and antibody. We keep assisting our clients from scientific research institutes and pharmaceutical enterprises in designing and developing their project schemes about discovery and verification of unknown targets, small-scaled and massive preparation of known protein/antibody, high-affinity antibody screening and process optimization. Continuous efforts have been made by us to improve the technical capacity and infrastructure construction in such fields as recombinant protein, traditional antibody, and recombinant antibody. Based on the increasingly improved technical capacity, we can provide and will launch more zero-risk services for the benefit of you in both capital and time cost.